• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于 22 例儿童和青少年自然杀伤/T 细胞淋巴瘤的临床病理和分子特征的回顾性研究。

A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.

机构信息

Department of Pathology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.

出版信息

Sci Rep. 2022 May 3;12(1):7118. doi: 10.1038/s41598-022-11247-z.

DOI:10.1038/s41598-022-11247-z
PMID:35504960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9064969/
Abstract

Natural killer/T-cell lymphoma (NKTCL) in children and adolescents is a rare type of T/NK cell neoplasms. The aim of the present study was to analyze the clinicopathological and genetic features of this rare entity of lymphoma. We evaluated the clinical, histopathological and molecular features of 22 young people with NKTCL, including 15 males and 7 females, with a median age of 15 years. The results revealed that the nasal site was the most involved region while non-nasal sites were observed in 27.3% out of all cases. The tumor cells were composed of small‑sized to large cells and 19 (86.4%) cases exhibited coagulative necrosis. The neoplastic cells in all patients were positive for CD3 and the cytotoxic markers. Nineteen (86.4%) cases were positive for CD56. Reduced expression of CD5 was observed in all available cases. CD30 was heterogeneously expressed in 15 (75.0%) cases. All 22 patients were EBV positive. Seven (36.8%) out of all the 19 patients during the follow-up died of the disease, and the median follow‑up period was 44 months. Moreover, patients treated with radiotherapy/chemotherapy showed significantly inferior OS compared with the untreated patients. High mutation frequencies were detected including KMT2C (5/5), MST1 (5/5), HLA-A (3/5) and BCL11A (3/5), which involved in modifications, tumor suppression and immune surveillance. These results suggest that NKTCL in children and adolescents exhibits histopathological and immunohistochemical features similar to the cases in adults. Active treatment is necessary after the diagnosis of NKTCL is confirmed. Furthermore, genetic analyse may provide a deep understanding of this rare disease.

摘要

儿童和青少年自然杀伤细胞/T 细胞淋巴瘤(NKTCL)是一种罕见的 T/NK 细胞肿瘤。本研究旨在分析这种罕见淋巴瘤实体的临床病理和遗传特征。我们评估了 22 例 NKTCL 年轻人的临床、组织病理学和分子特征,包括 15 例男性和 7 例女性,中位年龄为 15 岁。结果显示,鼻腔是最常见的受累部位,而所有病例中有 27.3%存在非鼻腔部位受累。肿瘤细胞由小至大细胞组成,19 例(86.4%)存在凝固性坏死。所有患者的肿瘤细胞均表达 CD3 和细胞毒性标志物。19 例(86.4%)患者表达 CD56。所有可评估病例均表现为 CD5 表达减少。CD30 在 15 例(75.0%)患者中呈异质性表达。所有 22 例患者均 EBV 阳性。19 例患者中有 7 例(36.8%)在随访期间死于该疾病,中位随访时间为 44 个月。此外,接受放疗/化疗的患者的总生存期明显劣于未治疗的患者。检测到高突变频率,包括 KMT2C(5/5)、MST1(5/5)、HLA-A(3/5)和 BCL11A(3/5),这些基因涉及修饰、肿瘤抑制和免疫监视。这些结果表明,儿童和青少年 NKTCL 具有与成人相似的组织病理学和免疫组织化学特征。确诊 NKTCL 后需要积极治疗。此外,遗传分析可能为深入了解这种罕见疾病提供帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a3/9064969/fdb3b7de3265/41598_2022_11247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a3/9064969/cf9be27fa347/41598_2022_11247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a3/9064969/fdb3b7de3265/41598_2022_11247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a3/9064969/cf9be27fa347/41598_2022_11247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a3/9064969/fdb3b7de3265/41598_2022_11247_Fig2_HTML.jpg

相似文献

1
A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.一项关于 22 例儿童和青少年自然杀伤/T 细胞淋巴瘤的临床病理和分子特征的回顾性研究。
Sci Rep. 2022 May 3;12(1):7118. doi: 10.1038/s41598-022-11247-z.
2
CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.CD56 阴性结外自然杀伤/T 细胞淋巴瘤:化疗联合或不联合 asparaginase 治疗 443 例患者的回顾性研究。
Front Immunol. 2022 Mar 17;13:829366. doi: 10.3389/fimmu.2022.829366. eCollection 2022.
3
Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.根据治疗方式探讨CD30表达在结外自然杀伤/T细胞淋巴瘤中的预后意义。
Leuk Lymphoma. 2015 Jun;56(6):1778-86. doi: 10.3109/10428194.2014.974048. Epub 2014 Nov 14.
4
CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.CD30 阳性皮肤结外自然杀伤/T 细胞淋巴瘤:临床病理特征和生存结局。
Int J Dermatol. 2019 Jun;58(6):688-696. doi: 10.1111/ijd.14362. Epub 2018 Dec 30.
5
Updating targets for natural killer/T-cell lymphoma immunotherapy.更新自然杀伤/T 细胞淋巴瘤免疫治疗的目标。
Cancer Biol Med. 2021 Feb 15;18(1):52-62. doi: 10.20892/j.issn.2095-3941.2020.0400.
6
[Ocular natural killer/T cell lymphoma: a clinicopathologic analysis].[眼自然杀伤/T细胞淋巴瘤:临床病理分析]
Zhonghua Yan Ke Za Zhi. 2019 May 11;55(5):374-380. doi: 10.3760/cma.j.issn.0412-4081.2019.05.012.
7
Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.表达自然杀伤细胞标志物CD56的鼻外型淋巴瘤:49例罕见侵袭性肿瘤的临床病理研究
Blood. 1997 Jun 15;89(12):4501-13.
8
Acute Epstein-Barr virus-positive cytotoxic T cell lymphoid hyperplasia in the upper aerodigestive tract, mimicking extranodal natural killer/T cell lymphoma, nasal type.上呼吸道和消化道的急性 EBV 阳性细胞毒性 T 细胞淋巴组织增生症,类似于结外 NK/T 细胞淋巴瘤,鼻型。
Virchows Arch. 2019 Feb;474(2):219-226. doi: 10.1007/s00428-018-2498-7. Epub 2018 Nov 28.
9
[Primary testicular NK/T cell lymphoma: a clinicopathologic analysis of six cases].[原发性睾丸NK/T细胞淋巴瘤:6例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2018 Mar 8;47(3):168-171. doi: 10.3760/cma.j.issn.0529-5807.2018.03.004.
10
Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.细胞毒性蛋白在外周T细胞淋巴瘤和自然杀伤细胞(NK)淋巴瘤中的表达:与结外部位、NK或Tγδ表型、间变性形态及CD30表达的关系
Leuk Lymphoma. 2000 Jul;38(3-4):317-26. doi: 10.3109/10428190009087022.

引用本文的文献

1
Orbital natural killer/T-cell lymphoma: a comprehensive case series and literature review.眼眶自然杀伤细胞/ T细胞淋巴瘤:一个综合病例系列及文献综述
BMC Cancer. 2025 Feb 28;25(1):372. doi: 10.1186/s12885-025-13761-5.
2
Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis.B细胞淋巴瘤/白血病11A在正常和恶性造血中的作用。
Biology (Basel). 2025 Jan 1;14(1):26. doi: 10.3390/biology14010026.
3
Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma.

本文引用的文献

1
Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas.结外 NK/T 细胞淋巴瘤中 HLA 和相关基因的频繁突变。
Leuk Lymphoma. 2021 Jan;62(1):95-103. doi: 10.1080/10428194.2020.1821011. Epub 2020 Sep 23.
2
BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma.BCL11A具有致癌性,并预示自然杀伤/T细胞淋巴瘤的预后不良。
Front Pharmacol. 2020 Jun 4;11:820. doi: 10.3389/fphar.2020.00820. eCollection 2020.
3
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
结外自然杀伤/T 细胞淋巴瘤中免疫组化 CD47 和信号调节蛋白-α表达的临床病理分析。
Ann Hematol. 2024 Aug;103(8):3033-3042. doi: 10.1007/s00277-024-05852-3. Epub 2024 Jun 18.
4
Novel target and treatment agents for natural killer/T-cell lymphoma.自然杀伤/T 细胞淋巴瘤的新型靶标和治疗药物。
J Hematol Oncol. 2023 Jul 22;16(1):78. doi: 10.1186/s13045-023-01483-9.
自然杀伤 T 细胞淋巴瘤的基因组和转录组特征。
Cancer Cell. 2020 Mar 16;37(3):403-419.e6. doi: 10.1016/j.ccell.2020.02.005.
4
Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.EB 病毒相关 T/NK 细胞淋巴组织增生性疾病:最新研究进展与诊断方法。
Pathology. 2020 Jan;52(1):111-127. doi: 10.1016/j.pathol.2019.09.011. Epub 2019 Nov 22.
5
Management of NK/T-Cell Lymphoma, Nasal Type.NK/T 细胞淋巴瘤,鼻型的治疗。
J Oncol Pract. 2019 Oct;15(10):513-520. doi: 10.1200/JOP.18.00719.
6
Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.激活的 hippo 信号通路抑制 NK/T 细胞淋巴瘤细胞的增殖并促进其凋亡。
Cancer Med. 2019 Jul;8(8):3892-3904. doi: 10.1002/cam4.2174. Epub 2019 May 23.
7
Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience.非上呼吸消化道 NK/T 细胞淋巴瘤患者的特征、预后因素和生存:17 年单中心经验。
Cancer Res Treat. 2019 Oct;51(4):1557-1567. doi: 10.4143/crt.2018.681. Epub 2019 Apr 1.
8
Molecular pathogenic pathways in extranodal NK/T cell lymphoma.结外 NK/T 细胞淋巴瘤的分子发病机制。
J Hematol Oncol. 2019 Apr 2;12(1):33. doi: 10.1186/s13045-019-0716-7.
9
Clinical differentiation of infectious mononucleosis that is caused by Epstein-Barr virus or cytomegalovirus: A single-center case-control study in Japan.由爱泼斯坦-巴尔病毒或巨细胞病毒引起的传染性单核细胞增多症的临床鉴别:日本一项单中心病例对照研究。
J Infect Chemother. 2019 Jun;25(6):431-436. doi: 10.1016/j.jiac.2019.01.012. Epub 2019 Feb 15.
10
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.阿基仑赛注射液治疗难治性大 B 细胞淋巴瘤的长期安全性和疗效(ZUMA-1):一项单臂、多中心、1-2 期临床试验。
Lancet Oncol. 2019 Jan;20(1):31-42. doi: 10.1016/S1470-2045(18)30864-7. Epub 2018 Dec 2.